Entacapone | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Entacapone
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Entacapone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 19 USDMF, 15 CEP/COS, 6 JDMF, 8 EU WC, 5 KDMF, 12 NDC API, 16 Listed Suppliers, $ API Reference Price

35 API Suppliers
19 USDMF
15 CEP/COS
6 JDMF
8 EU WC
5 KDMF
12 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

8 Intermediates Suppliers

8 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 35 FDA Orange Book, 100 Europe, 8 Canada, 1 Australia, 5 South Africa, 13 Listed Dossiers

162 FDF Dossiers
35 FDA Orange Book
100 Europe
8 Canada
1 Australia
5 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 200MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 5 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 41 Direct Compression, 32 Controlled & Modified Release, 30 Disintegrants & Superdisintegrants, 30 Solubilizers, 27 Granulation, 26 Thickeners and Stabilizers, 22 Parenteral, 22 Co-Processed Excipients, 20 Taste Masking, 18 Lubricants & Glidants, 18 Topical, 15 Film Formers & Plasticizers, 15 Chewable & Orodispersible Aids, 11 Emulsifying Agents, 9 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Rheology Modifiers

82 Fillers, Diluents & Binders
53 Coating Systems & Additives
41 Direct Compression
32 Controlled & Modified Release
30 Disintegrants & Superdisintegrants
30 Solubilizers
27 Granulation
26 Thickeners and Stabilizers
22 Parenteral
22 Co-Processed Excipients
20 Taste Masking
18 Lubricants & Glidants
18 Topical
15 Film Formers & Plasticizers
15 Chewable & Orodispersible Aids
11 Emulsifying Agents
9 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 13 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 84 Finished Drug Prices, 2 Annual Reports

2 US Medicaid Prescriptions
84 Finished Drug Prices
2 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

2 EDQM
2 USP
3 Others

$ API Ref.Price (USD/KG) : 225 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Gowling Strathy & Henderson

filter Patent Reset all filters

2 All

01 11334967

02 12342634

filter Product Reset all filters

2 All

01 2Entacapone

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 12012-03-28

02 12019-09-13

Product Main Page

01

Gowling Strathy & Henderson

Entacapone

Pharma, Lab & Chemical Expo

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-03-28

Date Granted : 1995-03-28

Brand Name : COMTAN

Patent Number : 1334967

Filing Date : 1987-11-27

Strength per Unit : 200mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-03-28

Date Granted : 1995-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Strathy & Henderson

Entacapone

Pharma, Lab & Chemical Expo

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-09-13

Date Granted : 2008-01-29

Brand Name : COMTAN

Patent Number : 2342634

Filing Date : 1999-09-13

Strength per Unit : 200mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-09-13

Date Granted : 2008-01-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?